Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

A new AI system from Mayo Clinic finds signs of the most common form of pancreatic cancer much earlier than standard ...

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.